

LATEST
-
REGULATORY
LDP HQ Finalizes Recommendations ahead of Growth Strategy
May 29, 2026 -
COLUMN
More Positions, More Candidates: A Snapshot of Movement in Japan’s Pharma Industry
May 29, 2026 -
BUSINESS
AGC Biologics Launches Bispecific Antibody CDMO Project in Japan
May 28, 2026
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…


